‘Visibility into marketing spend extremely challenging’: IPG withdraws 2020 financial target
CEO Michael Roth underscored IPG’s long track record of navigating successfully through uncertain economic periods.
News
Coronavirus Briefing: Brand reactions, frontline workers and a silent summer
Plus, some encouraging news from scientists about the virus.
‘The calls are coming in every day.’ Societies, firms go into high gear to retool live medical meetings for virtual consumption
Med-ed firms are seeing a spike in demand for digital services as the list of meetings cancelled or postponed grows due to coronavirus.
Five things for pharma marketers to know: Thursday, March 26, 2020
WHO deems virus “Public Enemy No. 1;” NYC closes some streets to cars to allow for social distancing; Ventilator demand is 10 times what’s available.
Omnicom CEO John Wren tout’s holding company’s cash reserves
The network has $4.3 billion in cash and cash equivalents, Wren says.
Coronavirus Briefing: Aid deals, contracts and hospitality
Plus, one piece of “good news” about air pollution.
Report: Maintaining brand relevance while the COVID-19 outbreak rages
As the COVID-19 outbreak has taken over the collective consciousness, brands that engage in conversation and show real action are remaining relevant, a W2O report found.
Design an album cover for your firm for the 2020 Agency 100
Whether you design something entirely from scratch or channel your inner Wu Tang and recreate the 36 Chambers, we’re excited to see what you come up with.
Five things for pharma marketers to know: Wednesday, March 25, 2020
U.S. may become coronavirus epicenter; ASCO moves conference online; Many drug trials have been postponed due to COVID-19.
FDA and CDC promote telemedicine during COVID-19 outbreak
The federal health agencies have taken steps to provide better telemedicine services during the outbreak.
Want to read more?
Please login or register first to view this content.
